AMB Fundamental Analysis - AMBROMOBILIARE

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to AMB. AMB was compared to 121 industry peers in the Capital Markets industry. AMB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AMB has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year AMB has reported negative net income.

In the past year AMB had a positive cash flow from operations.

In multiple years AMB reported negative net income over the last 5 years.

In the past 5 years AMB reported 4 times negative operating cash flow.

1.2 Ratios

The Return On Assets of AMB (-8.34%) is worse than 73.55% of its industry peers.

Looking at the Return On Equity, with a value of -11.95%, AMB is doing worse than 71.07% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-8.34%
ROE	-11.95%
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

In the last couple of years the Profit Margin of AMB has declined.

In the last couple of years the Operating Margin of AMB has declined.

AMB has a Gross Margin (16.93%) which is comparable to the rest of the industry.

In the last couple of years the Gross Margin of AMB has declined.

The Profit Margin and Operating Margin are not available for AMB so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	16.93%

OM growth 3Y-54.88%

OM growth 5Y-34.84%

PM growth 3Y-51.15%

PM growth 5Y-30.96%

GM growth 3Y-18.6%

GM growth 5Y-23.91%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

There is no outstanding debt for AMB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of 1.31, we must say that AMB is in the distress zone and has some risk of bankruptcy.

AMB has a Altman-Z score of 1.31. This is comparable to the rest of the industry: AMB outperforms 59.50% of its industry peers.

The Debt to FCF ratio of AMB is 2.56, which is a good value as it means it would take AMB, 2.56 years of fcf income to pay off all of its debts.

Looking at the Debt to FCF ratio, with a value of 2.56, AMB belongs to the top of the industry, outperforming 83.47% of the companies in the same industry.

AMB has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.

AMB has a better Debt to Equity ratio (0.14) than 73.55% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.14
Debt/FCF	2.56
Altman-Z	1.31

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

AMB has a Current Ratio of 1.74. This is a normal value and indicates that AMB is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Current ratio, with a value of 1.74, AMB belongs to the top of the industry, outperforming 80.17% of the companies in the same industry.

A Quick Ratio of 1.74 indicates that AMB should not have too much problems paying its short term obligations.

AMB's Quick ratio of 1.74 is amongst the best of the industry. AMB outperforms 80.99% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.74
Quick Ratio	1.74

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

AMB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -76.31%.

The earnings per share for AMB have been decreasing by -39.32% on average. This is quite bad

AMB shows a strong growth in Revenue. In the last year, the Revenue has grown by 34.35%.

Measured over the past years, AMB shows a very negative growth in Revenue. The Revenue has been decreasing by -11.66% on average per year.

EPS 1Y (TTM)-76.31%

EPS 3Y-64.01%

EPS 5Y-39.32%

EPS Q2Q%-885.71%

Revenue 1Y (TTM)34.35%

Revenue growth 3Y-26.3%

Revenue growth 5Y-11.66%

Sales Q2Q%-60.85%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

AMB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of AMB indicates a rather cheap valuation: AMB is cheaper than 85.95% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	9.46
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

AMB does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

AMBROMOBILIARE

BIT:AMB (11/28/2025, 7:00:00 PM)

0.75

-0.11 (-13.29%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners26.31%

Ins Owner ChangeN/A

Market Cap2.04M

Revenue(TTM)2.33M

Net Income(TTM)-358.50K

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.87
P/FCF	9.46
P/OCF	9.46
P/B	0.68
P/tB	2.98
EV/EBITDA	N/A

EPS(TTM)-0.13

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0.08

FCFY10.57%

OCF(TTM)0.08

OCFY10.57%

SpS0.86

BVpS1.1

TBVpS0.25

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-8.34%
ROE	-11.95%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	16.93%
FCFM	9.25%

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3Y-54.88%

OM growth 5Y-34.84%

PM growth 3Y-51.15%

PM growth 5Y-30.96%

GM growth 3Y-18.6%

GM growth 5Y-23.91%

F-Score4

Asset Turnover0.54

Health

		Industry Rank	Sector Rank
Debt/Equity	0.14
Debt/FCF	2.56
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.74
Quick Ratio	1.74
Altman-Z	1.31

F-Score4

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-76.31%

EPS 3Y-64.01%

EPS 5Y-39.32%

EPS Q2Q%-885.71%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)34.35%

Revenue growth 3Y-26.3%

Revenue growth 5Y-11.66%

Sales Q2Q%-60.85%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-17.93%

EBIT growth 3Y-66.75%

EBIT growth 5Y-42.44%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y160.97%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y188.25%

OCF growth 3YN/A

OCF growth 5YN/A

AMBROMOBILIARE / AMB.MI FAQ

What is the ChartMill fundamental rating of AMBROMOBILIARE (AMB.MI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to AMB.MI.

Can you provide the valuation status for AMBROMOBILIARE?

ChartMill assigns a valuation rating of 2 / 10 to AMBROMOBILIARE (AMB.MI). This can be considered as Overvalued.

Can you provide the profitability details for AMBROMOBILIARE?

AMBROMOBILIARE (AMB.MI) has a profitability rating of 1 / 10.

AMBROMOBILIARE (AMB.MI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

AMBROMOBILIARE / AMB.MI FAQ

What is the ChartMill fundamental rating of AMBROMOBILIARE (AMB.MI) stock?

Can you provide the valuation status for AMBROMOBILIARE?

Can you provide the profitability details for AMBROMOBILIARE?